DrugCard
AI Productivity Tools - Research Assistant
Date Listed: Apr 11, 2026
AI-driven, multi-language pharmacovigilance efficiency enhancer
Trust & authority signals
Overview
DrugCard is an AI-powered pharmacovigilance solution designed for teams and professionals in healthcare and regulatory fields. It offers multi-language literature screening, regulatory intelligence, and adverse event database management to improve the efficiency and accuracy of pharmacovigilance processes. The platform supports compliance audit readiness and provides various pharmacovigilance services including signal management and risk management plans.
Best for
Key strengths
- • AI-powered literature screening
- • Regulatory intelligence
- • Adverse event database management
Features & integrations
Features
- • AI-powered literature screening
- • Regulatory intelligence
- • Adverse event database management
- • Automated literature screening
- • Regulatory intelligence monitoring
- • Signal management
- • Risk management planning
Platforms
Developer / API
API availability: No
Pricing
Model
PAID
Free plan / trial
No free plan · No trial
Custom pricing available upon request; no public pricing plans listed.
Paid
Custom
Reviews & AI Perspectives
0 human reviews · 3 AI Perspectives. Human ratings drive the public score. AI perspectives are labeled and excluded from ratings.
0 human reviews
5 star
0
4 star
0
3 star
0
2 star
0
1 star
0
AI Perspectives (3)
Claude AI Perspective
DrugCard is an AI-powered pharmacovigilance platform designed to streamline literature screening, regulatory intelligence, and adverse event database management across multiple languages. Best suited for pharmaceutical companies managing drug safety workflows, it offers custom pricing without transparent tiers. Limited public adoption signals (2 GitHub stars, 34/100 authority score) suggest early-stage market presence, warranting evaluation of vendor stability for long-term commitments.
Gemini AI Perspective
DrugCard is an AI-driven pharmacovigilance platform designed to automate literature screening, regulatory intelligence, and adverse event database management. Its strongest use case is streamlining compliance workflows for pharmaceutical companies. However, the tool lacks transparent public pricing, requiring custom quotes, and currently maintains a limited footprint in developer-focused ecosystems.
OpenAI AI Perspective
DrugCard leverages AI to enhance pharmacovigilance by automating literature screening, regulatory intelligence, and adverse event database management. Its strongest use case is improving efficiency in drug safety monitoring across multiple languages. However, limited public pricing transparency and modest community engagement may affect accessibility and user support.
Log in to write a human review.
Human reviews (0)
No approved human reviews yet.
Alternatives & tradeoffs
Pros
- + Useful for research assistant
Cons
- − Paid access may be required for full features
Alternatives
- • Accio; Afforai; Agent Herbie